Accumulation of Arsenic Speciation and In Vivo Toxicity Following Oral Administration of a Chinese Patent Medicine Xiao-Er-Zhi-Bao-Wan in Rats | |
Luo, Jiaoyang; Han, Xu; Dou, Xiaowen; Zhang, Lei; Yang, Shihai; Yang, Meihua | |
2017 | |
卷号 | 8页码:491 |
关键词 | Xiao-Er-Zhi-Bao-Wan arsenic speciation toxicity histopathology blood biochemistry |
ISSN号 | 1663-9812 |
DOI | 10.3389/fphar.2017.00491 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6365445 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Luo, Jiaoyang,Han, Xu,Dou, Xiaowen,et al. Accumulation of Arsenic Speciation and In Vivo Toxicity Following Oral Administration of a Chinese Patent Medicine Xiao-Er-Zhi-Bao-Wan in Rats[J],2017,8:491. |
APA | Luo, Jiaoyang,Han, Xu,Dou, Xiaowen,Zhang, Lei,Yang, Shihai,&Yang, Meihua.(2017).Accumulation of Arsenic Speciation and In Vivo Toxicity Following Oral Administration of a Chinese Patent Medicine Xiao-Er-Zhi-Bao-Wan in Rats.,8,491. |
MLA | Luo, Jiaoyang,et al."Accumulation of Arsenic Speciation and In Vivo Toxicity Following Oral Administration of a Chinese Patent Medicine Xiao-Er-Zhi-Bao-Wan in Rats".8(2017):491. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论